COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $339,339 | -53.0% | 14,145 | -65.3% | 0.02% | -44.7% |
| Q2 2022 | $722,000 | -36.4% | 40,738 | -26.9% | 0.04% | -36.7% |
| Q1 2022 | $1,135,000 | +15.0% | 55,739 | +5.5% | 0.06% | 0.0% |
| Q4 2021 | $987,000 | +33.0% | 52,815 | +40.5% | 0.06% | +42.9% |
| Q3 2021 | $742,000 | -30.0% | 37,589 | -16.1% | 0.04% | -26.3% |
| Q2 2021 | $1,060,000 | -4.2% | 44,827 | -4.0% | 0.06% | -9.5% |
| Q1 2021 | $1,107,000 | +4.2% | 46,702 | -11.9% | 0.06% | -18.2% |
| Q4 2020 | $1,062,000 | -62.8% | 53,020 | -61.3% | 0.08% | -17.2% |
| Q3 2020 | $2,853,000 | -7.8% | 137,049 | -22.5% | 0.09% | +16.2% |
| Q2 2020 | $3,095,000 | +54.9% | 176,854 | +44.5% | 0.08% | +50.9% |
| Q1 2020 | $1,998,000 | -32.0% | 122,381 | -14.3% | 0.05% | +29.3% |
| Q4 2019 | $2,939,000 | +798.8% | 142,799 | +400.7% | 0.04% | +925.0% |
| Q3 2019 | $327,000 | – | 28,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $34,840,000 | 5.65% |
| SECTORAL ASSET MANAGEMENT INC | 1,426,862 | $26,340,000 | 3.29% |
| Eventide Asset Management | 2,207,610 | $40,752,000 | 2.12% |
| Rock Springs Capital Management LP | 1,885,729 | $34,811,000 | 1.58% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 460,000 | $8,492,000 | 1.11% |
| Cormorant Asset Management, LP | 300,000 | $5,538,000 | 0.58% |
| HIGHLAND CAPITAL MANAGEMENT LP | 579,234 | $10,693,000 | 0.49% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,389,863 | $25,657,000 | 0.39% |
| NBW CAPITAL LLC | 69,050 | $1,275,000 | 0.34% |
| NEXT CENTURY GROWTH INVESTORS LLC | 144,972 | $2,676,000 | 0.33% |